SCHEMBL4644935

SCHEMBL4644935

COc1ccc(-c2cnc(-n3c(=O)[nH]c4ccccc43)nc2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 10/20 0.52
MAP3K11 Q16584 1/20 0.48
PARP1 P09874 1/20 0.46
PDE6C P51160 2/20 0.45
PDE11A Q9HCR9 2/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
VCP P55072 1/20 0.44
TLR9 Q9NR96 1/20 0.43
TLR8 Q9NR97 1/20 0.43
TLR7 Q9NYK1 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
GUSB P08236 1/20 0.43
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRG2 P18507 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4646649 0.89 PDE4A (0.54) PDE5ATLR9TLR8TLR7PDE4A
SCHEMBL4645500 0.83 GABRP (0.50) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4642768 0.82 MAP3K11 (0.50) MAP3K11PARP1KDM4EALDH1A1HPGD
SCHEMBL4645023 0.78 PDE4A (0.53) PDE4APDE4BPDE4CPDE4D
SCHEMBL28904576 0.77 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10GABRP
SCHEMBL30615640 0.77 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10GABRP
SCHEMBL9117643 0.76 PTPN1 (0.49) KDM4EALDH1A1HPGDHSD17B10VCP
SCHEMBL4645200 0.75 ALDH1A1 (0.43) PDE5AMAP3K11KDM4EALDH1A1HPGD
SCHEMBL14214630 0.74 LCK (0.51) VCPGABRPGABRDGABRA1GABRB1
SCHEMBL4645167 0.73 PDE4D (0.44) MAP3K11PARP1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207659-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE 4 RANBAXY LABORATORIES LIMITED (IN) 2008-08-28 US claimed
US-20080207659-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE 4 RANBAXY LABORATORIES LIMITED (IN) 2008-08-28 US disclosed
EP-1958947-A1 Inhibitors of phosphodiesterase type 4 Ranbaxy Laboratories Limited (IN) 2008-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207659-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE 4 PDE4A, PDE4B, PDE4C PDE5A 4/4885MAP3K11 912/4885PARP1 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.